Odimma

Illkirch-graffenstaden, France

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

$2.0M raised

Apr 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Odimma raised?

Odimma has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in April 2023.

Who are Odimma's investors?

Odimma's investors include Bpifrance, Alsace Business Angels, Capital Grand Est, Angels Santé.

Where is Odimma headquartered?

Odimma is headquartered in Illkirch-graffenstaden, France.

What does Odimma do?

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

What stage is Odimma at?

Odimma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2023.

MLA

"Odimma — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/odimma. Accessed July 2, 2026.

APA

VCBacked. (2023). Odimma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/odimma

Wikipedia (cite web)

{{cite web |title=Odimma — Funding & Investors |url=https://www.vcbacked.co/company/odimma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2023.